158 related articles for article (PubMed ID: 33364830)
1. The Significance of Platelet-Albumin-Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count.
Pang Q; Liu S; Wang L; Pan H; Wang C; Zhou L; Lu Y; Liu H
Cancer Manag Res; 2020; 12():12811-12822. PubMed ID: 33364830
[TBL] [Abstract][Full Text] [Related]
2. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
Wu B; Hu X; Jin H; Zhou L; Zhang D; Man Z; Wang Y; Yang S; Pang Q; Liu H; Cui P
Medicine (Baltimore); 2019 Oct; 98(43):e17394. PubMed ID: 31651841
[TBL] [Abstract][Full Text] [Related]
3. Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia.
Man ZR; Gong XK; Qu KL; Pang Q; Wu BQ
World J Gastrointest Oncol; 2024 May; 16(5):1763-1772. PubMed ID: 38764822
[TBL] [Abstract][Full Text] [Related]
4. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
[TBL] [Abstract][Full Text] [Related]
5. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X
Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
Wang ZX; Peng W; Zhang XY; Wen TF; Li C
Medicine (Baltimore); 2021 Mar; 100(11):e24476. PubMed ID: 33725934
[TBL] [Abstract][Full Text] [Related]
7. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
Lee SK; Song MJ; Kim SH; Park M
PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
[TBL] [Abstract][Full Text] [Related]
8. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
Luo HM; Zhao SZ; Li C; Chen LP
Medicine (Baltimore); 2018 Mar; 97(12):e0226. PubMed ID: 29561452
[TBL] [Abstract][Full Text] [Related]
9. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT).
Ho CHM; Chiang CL; Lee FAS; Choi HCW; Chan JCH; Yeung CSY; Huang JJ; Chan MKH; Blanck O; Wong FCS
Oncotarget; 2018 Jun; 9(48):28818-28829. PubMed ID: 29988960
[TBL] [Abstract][Full Text] [Related]
10. Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?
Jaruvongvanich V; Sempokuya T; Wong L
J Gastrointest Oncol; 2018 Aug; 9(4):750-761. PubMed ID: 30151272
[TBL] [Abstract][Full Text] [Related]
11. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
[TBL] [Abstract][Full Text] [Related]
12. Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.
Lu LH; Zhang YF; Mu-Yan C; Kan A; Zhong XP; Mei J; Ling YH; Li SH; Shi M; Wei W; Guo RP
Dig Liver Dis; 2019 Oct; 51(10):1430-1437. PubMed ID: 31054962
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery.
Han R; Tian Z; Jiang Y; Guan G; Sun X; Yu Y; Zhang L; Zhou J; Jing X
Gland Surg; 2022 Mar; 11(3):576-587. PubMed ID: 35402206
[TBL] [Abstract][Full Text] [Related]
14. Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score.
Wang Q; Sheng S; Xiong Y; Han M; Jin R; Hu C
Front Immunol; 2024; 15():1409443. PubMed ID: 38863693
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Platelet-Albumin-Bilirubin Grade in Child-Pugh A and B Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Liu R; Li R; Zhang M; Liu W; Li H; Li D
Front Oncol; 2022; 12():914997. PubMed ID: 35912198
[TBL] [Abstract][Full Text] [Related]
16. Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin grade: A Preliminary Study.
Huang Z; Zuo M; Ni J; Gu Y; Zhang T; Jiang Y; Zhuo S; An C; Huang J
Cancer Manag Res; 2020; 12():1373-1385. PubMed ID: 32158269
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
Kut E; Menekse S
Sci Rep; 2024 Jan; 14(1):1371. PubMed ID: 38228667
[TBL] [Abstract][Full Text] [Related]
18. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
[No Abstract] [Full Text] [Related]
19. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.
Oikonomou T; Goulis L; Doumtsis P; Tzoumari T; Akriviadis E; Cholongitas E
Ann Hepatol; 2019; 18(1):126-136. PubMed ID: 31113581
[TBL] [Abstract][Full Text] [Related]
20. Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma.
Sonohara F; Yamada S; Tanaka N; Tashiro M; Sunagawa Y; Morimoto D; Tanaka H; Takami H; Hayashi M; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
Hepatol Res; 2019 Nov; 49(11):1305-1315. PubMed ID: 31260575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
